These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 329806)

  • 41. [Pharmacology of calcium antagonists].
    Klaus W
    Fortschr Med; 1984 Jul; 102(27-28):728-31. PubMed ID: 6479816
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The use of propranolol and verapamil in patients with ischemic heart disease].
    Chizh VD
    Vrach Delo; 1990 Feb; (2):15-8. PubMed ID: 2339541
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effect of verapamil on left ventricular contraction in patients with coronary disease].
    Goch JH; Kuklewicz C; Organiszczak K; Tkaczewski W
    Wiad Lek; 1976 Sep; 29(17):1502-4. PubMed ID: 983029
    [No Abstract]   [Full Text] [Related]  

  • 44. [The antiarrhythmic and coronary-dilating properties of verapamil in patients ith ischemic heart disease].
    Votcal BE; Lozinskij LG; Goldberg VA; Venediktova MG; Gribova OA
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1281+. PubMed ID: 5312386
    [No Abstract]   [Full Text] [Related]  

  • 45. [Polygraphic and electrocardiographic study of a new coronary therapeutic agent: dilazep].
    Parenti B; Selvaggi R
    Clin Ter; 1980 Jan; 92(2):155-63. PubMed ID: 7389275
    [No Abstract]   [Full Text] [Related]  

  • 46. Verapamil: an effective calcium blocking agent for pediatric patients.
    Porter CJ; Garson A; Gillette PC
    Pediatrics; 1983 May; 71(5):748-55. PubMed ID: 6340050
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential effects of mibefradil, verapamil, and amlodipine on myocardial function and intracellular Ca(2+) handling in rats with chronic myocardial infarction.
    Min JY; Sandmann S; Meissner A; Unger T; Simon R
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1038-44. PubMed ID: 10565822
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of verapamil on coronary hemodynamics in patients with coronary heart disease.
    Simonsen S
    Eur J Cardiol; 1978 Aug; 8(1):9-18. PubMed ID: 689073
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antiarrhythmic, electrophysiologic and hemodynamic effects of ACC-9358.
    Brown BS; Calzadilla SV; Diemer MJ; Hartman JC; Reynolds RD
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1225-34. PubMed ID: 3694532
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antiarrhythmic, hemodynamic and cardiac electrophysiological evaluation of N-(2,6-dimethylphenyl)-N'-[3-(1-methylethylamino)propyl]urea (Wy-42,362).
    Bergey JL; Sulkowski T; Much DR; Wendt RL
    Arzneimittelforschung; 1983; 33(9):1258-68. PubMed ID: 6685506
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiovascular actions of niludipine (BAY a 7168), a new dihydropyridine vasodilator, in the dog.
    Taira N; Narimatsu A; Satoh K; Himori N; Imai Y; Hiwatari M
    Arzneimittelforschung; 1979; 29(2):246-55. PubMed ID: 582137
    [No Abstract]   [Full Text] [Related]  

  • 52. [Isoproterenol induces ST-segment elevation without wall motion aggravation and myocardial ischemia in experimental myocardial infarction].
    Yamamoto T; Katori R
    J Cardiol; 1995 Sep; 26(3):167-75. PubMed ID: 7473047
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The prolonged use of calcium antagonists in myocardial infarct in rats: their effect on hemodynamics and the contractile function and morphology of the heart muscle].
    Kazanova GV; Tsorin IB; Chichkanov GG; Zakharov SP; Shchegolev AI; Iavorskiĭ AN; Liubimov BI
    Eksp Klin Farmakol; 1992; 55(3):17-20. PubMed ID: 1458153
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Use of verapamil in the treatment of ventricular extrasystole in chronic Chagas' heart disease].
    Vichi FL; Nobre F; Evora P; Ribeiro PJ; Papa MV
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():101-6. PubMed ID: 407891
    [No Abstract]   [Full Text] [Related]  

  • 55. Hemodynamic effects of verapamil and practolol in man.
    Seabra-Gomes R; Rickards A; Sutton R
    Eur J Cardiol; 1976 Mar; 4(1):79-85. PubMed ID: 1261583
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Antia-angina effect of verapamil through the clinical and ergometric evaluation].
    Castro I; Pereira FA; Rodrigues R
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():75-7. PubMed ID: 329812
    [No Abstract]   [Full Text] [Related]  

  • 57. [Effect of trimecaine on systolic phasic structure of the left ventricle, hemodynamic indices and intracardiac conductivity].
    Kamf GC
    Kardiologiia; 1982; 22(7):117-8. PubMed ID: 7109440
    [No Abstract]   [Full Text] [Related]  

  • 58. [Evaluation and use of the coronary and anti-arrhythmic drug Lidoflazin. Clinical, electrocardiographic, hemodynamic, and laboratory-chemical studies on 187 patients].
    Lehmann HU; Ghabussi P; Hochrein H
    Med Welt; 1977 Feb; 28(8):386-90. PubMed ID: 321914
    [No Abstract]   [Full Text] [Related]  

  • 59. [Changes in the indicators of intracardiac hemodynamics in patients with post-infarction cardiosclerosis under the action of verapamil].
    Komissarov VA
    Kardiologiia; 1990 Aug; 30(8):60-3. PubMed ID: 2147729
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of the optimal dose of finoptin on various components of the circulatory system in heart failure in patients with ischemic heart disease].
    Denisiuk VI; Belokonnaia NS
    Kardiologiia; 1990 Jul; 30(7):72-4. PubMed ID: 2232469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.